Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Children 2 months to 17 years (i.e. before their 18th birthday)~* Child will be receiving intranasal dexmedetomidine as part of their usual medical care~* Child will be undergoing a non-painful medical procedure, which includes (but is not limited to): MRI, CT scans, ABR/BAER, echocardiograms, and EEGs.~Exclusion Criteria:~* Known allergy to dexmedetomidine~* Known abnormal renal or hepatic function~* Known cardiac conduction abnormality or heart block~* Current use of digoxin or beta-blockers

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Intranasal dexmedetomidine (Type: None): Intranasal dexmedetomidine (100 mcg/mL), 0.5 to 4 mcg/kg

Based on this trial design, predict the completion outcome and termination type (if applicable).